Stock listing
NASDAQ:BIVI BioVie Inc. Stock
Home listing (NASDAQ) of BioVie Inc.
Follow BioVie Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BIVI
$0.943 USD -0.052 (-5.3%)
Close on Nov 18, 2026
- Day range
- $0.930 – $1.046 USDNov 18, 2026
- Volume
- 183,511 sharesNov 18, 2026
- Market cap
- $10.11M USDAt the close on Nov 18, 2026 · price × 10.72M shares outstanding
- 52-week range
- $0.820 – $3.790 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $3.93M USDMedian day 256,323 shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BIVI · Home | $0.943 USD | -0.052 (-5.3%) | 183,511 | $1.040 | $1.046 | $0.930 | $0.995 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:BIVI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.943 | -0.052 | -5.3% | $1.040 | $1.046 | $0.930 | 183,511 | |
| $0.995 | -0.085 | -7.8% | $1.080 | $1.080 | $0.940 | 439,854 | |
| $1.080 | -0.050 | -4.4% | $1.150 | $1.165 | $1.060 | 158,729 | |
| $1.130 | -0.060 | -5.0% | $1.190 | $1.230 | $1.130 | 214,938 | |
| $1.190 | -0.070 | -5.6% | $1.230 | $1.240 | $1.160 | 163,103 | |
| $1.260 | -0.010 | -0.8% | $1.280 | $1.320 | $1.240 | 137,606 | |
| $1.270 | -0.030 | -2.3% | $1.290 | $1.350 | $1.250 | 295,658 | |
| $1.300 | -0.030 | -2.3% | $1.400 | $1.400 | $1.280 | 164,364 | |
| $1.330 | +0.120 | +9.9% | $1.250 | $1.380 | $1.230 | 184,386 | |
| $1.210 | -0.130 | -9.7% | $1.290 | $1.310 | $1.105 | 488,213 | |
| $1.340 | -0.390 | -22.5% | $1.640 | $1.650 | $1.230 | 1,108,131 | |
| $1.730 | +0.360 | +26.3% | $1.450 | $2.660 | $1.400 | 13,523,350 | |
| $1.370 | -0.060 | -4.2% | $1.410 | $1.430 | $1.310 | 120,889 | |
| $1.430 | +0.050 | +3.6% | $1.390 | $1.490 | $1.380 | 105,100 | |
| $1.380 | -0.080 | -5.5% | $1.430 | $1.460 | $1.370 | 41,900 | |
| $1.460 | +0.020 | +1.4% | $1.490 | $1.490 | $1.412 | 106,700 | |
| $1.440 | +0.110 | +8.3% | $1.370 | $1.450 | $1.340 | 195,900 | |
| $1.330 | +0.090 | +7.3% | $1.250 | $1.360 | $1.250 | 139,000 | |
| $1.240 | -0.040 | -3.1% | $1.280 | $1.300 | $1.230 | 141,650 | |
| $1.280 | +0.020 | +1.6% | $1.240 | $1.290 | $1.215 | 101,048 | |
| $1.260 | +0.020 | +1.6% | $1.210 | $1.277 | $1.150 | 195,074 | |
| $1.240 | -0.130 | -9.5% | $1.400 | $1.450 | $1.240 | 279,510 | |
| $1.370 | +0.170 | +14.2% | $1.290 | $1.390 | $1.204 | 182,520 | |
| $1.200 | +0.070 | +6.2% | $1.130 | $1.220 | $1.120 | 275,926 | |
| $1.130 | -0.030 | -2.6% | $1.180 | $1.190 | $1.130 | 166,880 | |
| $1.160 | -0.040 | -3.3% | $1.200 | $1.250 | $1.150 | 342,644 | |
| $1.200 | -0.120 | -9.1% | $1.300 | $1.331 | $1.200 | 171,968 | |
| $1.320 | -0.070 | -5.0% | $1.410 | $1.441 | $1.310 | 67,349 | |
| $1.390 | +0.110 | +8.6% | $1.300 | $1.400 | $1.275 | 204,863 | |
| $1.280 | -0.120 | -8.6% | $1.370 | $1.390 | $1.250 | 362,156 | |
| $1.400 | -0.040 | -2.8% | $1.460 | $1.470 | $1.400 | 134,616 | |
| $1.440 | 0.000 | 0.0% | $1.440 | $1.500 | $1.440 | 132,707 | |
| $1.440 | -0.020 | -1.4% | $1.430 | $1.480 | $1.420 | 135,119 | |
| $1.460 | -0.010 | -0.7% | $1.470 | $1.520 | $1.460 | 189,852 | |
| $1.470 | -0.050 | -3.3% | $1.530 | $1.535 | $1.460 | 266,171 | |
| $1.520 | -0.020 | -1.3% | $1.570 | $1.580 | $1.500 | 201,338 | |
| $1.540 | 0.000 | 0.0% | $1.550 | $1.610 | $1.520 | 146,520 | |
| $1.540 | -0.065 | -4.0% | $1.570 | $1.600 | $1.530 | 182,616 | |
| $1.605 | -0.005 | -0.3% | $1.660 | $1.750 | $1.580 | 458,952 | |
| $1.610 | -0.020 | -1.2% | $1.600 | $1.645 | $1.595 | 235,841 | |
| $1.630 | 0.000 | 0.0% | $1.630 | $1.660 | $1.590 | 216,462 | |
| $1.630 | 0.000 | 0.0% | $1.650 | $1.710 | $1.610 | 201,659 | |
| $1.630 | +0.020 | +1.2% | $1.640 | $1.760 | $1.620 | 411,521 | |
| $1.610 | -0.170 | -9.6% | $1.780 | $1.840 | $1.610 | 406,800 | |
| $1.780 | +0.060 | +3.5% | $1.820 | $1.841 | $1.750 | 478,847 | |
| $1.720 | -0.030 | -1.7% | $1.760 | $1.825 | $1.685 | 439,983 | |
| $1.750 | -0.300 | -14.6% | $1.900 | $1.908 | $1.565 | 1,154,667 | |
| $2.050 | +0.120 | +6.2% | $1.900 | $2.120 | $1.880 | 630,141 | |
| $1.930 | +0.020 | +1.0% | $1.920 | $2.020 | $1.910 | 170,760 | |
| $1.910 | -0.060 | -3.0% | $1.950 | $1.990 | $1.890 | 261,851 | |
| $1.970 | -0.100 | -4.8% | $2.040 | $2.120 | $1.900 | 351,367 | |
| $2.070 | +0.070 | +3.5% | $2.055 | $2.200 | $2.000 | 320,028 | |
| $2.000 | -0.030 | -1.5% | $2.040 | $2.080 | $1.960 | 296,762 | |
| $2.030 | 0.000 | 0.0% | $2.020 | $2.120 | $2.005 | 250,794 | |
| $2.030 | -0.210 | -9.4% | $2.250 | $2.270 | $2.000 | 519,399 | |
| $2.240 | -0.040 | -1.8% | $2.300 | $2.450 | $2.180 | 486,559 | |
| $2.280 | +0.120 | +5.6% | $2.374 | $2.490 | $2.280 | 1,551,930 | |
| $2.160 | -0.030 | -1.4% | $2.200 | $2.250 | $2.106 | 485,693 | |
| $2.190 | +0.080 | +3.8% | $2.090 | $2.220 | $2.000 | 763,384 | |
| $2.110 | +0.020 | +1.0% | $2.005 | $2.250 | $1.967 | 922,448 | |
| $2.090 | -0.050 | -2.3% | $2.000 | $2.110 | $1.930 | 1,029,902 | |
| $2.140 | +0.190 | +9.7% | $1.812 | $2.145 | $1.760 | 2,173,771 | |
| $1.950 | +0.090 | +4.8% | $2.155 | $2.480 | $1.800 | 19,763,840 | |
| $1.860 | +0.520 | +38.8% | $1.545 | $2.390 | $1.490 | 49,110,641 | |
| $1.340 | +0.376 | +38.9% | $1.300 | $1.440 | $1.140 | 42,468,762 | |
| $0.964 | -0.206 | -17.6% | $1.130 | $1.140 | $0.945 | 10,538,110 |
Splits
2 splits since 2024 · NASDAQ:BIVI · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation | |
| 1-for-10 | Consolidation |
- Ticker
- NASDAQ:BIVI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
BioVie Presents New Biomarker Data Highlighting Biomarker-Defined Endotypes and Neuropeptide Y Response to Bezisterim at the 4th Long COVID International Conference 2026
Nov 16, 2026
Closed $1.08 (-4.4%) on Nov 16, 2026
BioVie Invited to Present Data on Bezisterim in Parkinson’s Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson’s Diseases
Nov 10, 2026
Closed $1.27 (-2.3%) on Nov 10, 2026
BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop
Nov 9, 2026
Closed $1.30 (-2.3%) on Nov 9, 2026
BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Nov 4, 2026
Closed $1.34 (-22.5%) on Nov 4, 2026
BioVie Selected for Late-Breaking Oral Presentation of Bezisterim Long COVID Data at the 4th Long COVID International Conference 2026
Nov 2, 2026
Closed $1.37 (-4.2%) on Nov 2, 2026
BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop
Oct 26, 2026
Closed $1.33 (+7.3%) on Oct 26, 2026
BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
Oct 20, 2026
Closed $1.24 (-9.5%) on Oct 20, 2026
BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting
Oct 19, 2026
Closed $1.37 (+14.2%) on Oct 19, 2026
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
Oct 14, 2026
Closed $1.16 (-3.3%) on Oct 14, 2026
New to The Street Broadcasts Tonight at 6: 30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global
Sep 19, 2026
Closed $1.63 (+1.2%) on Sep 21, 2026
Issued by another party
Financings
Registered direct offering of shares of common stock and concurrent private placement common warrants
Nov 4, 2026
Announced: about US$4.74M · US$1.6 a share · ½ warrant at US$1.7 for 66 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and general corporate purposes
Public offering of units (one share of common stock and one warrant) or pre-funded units
Aug 11, 2025
Closed: US$12M raised · US$2 a unit · 1 warrant at US$2.5 for 60 months · ThinkEquity
Dealers: ThinkEquity (lead)
Use of proceeds: Working capital and general corporate purposes
Decks
Longevity Biotech, Boston, MA (October 2025)
Conference · 22 slides · Oct 23, 2025
Investor Presentation (April 2025)
Investor deck · 44 slides · April 2025
2024 World Congress on Parkinson's Disease and Related Disorders
Conference · 13 slides · May 2024
12th Annual Alzheimer's and Parkinson's Drug Development Summit 2024
Conference · 27 slides · April 2024
BioVie Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 27 in the last 12 months · 120 in all · newest Nov 16, 2026 · oldest 2019
- Decks
- 25 decks · latest Oct 23, 2025
Where BioVie Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BIVI · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BIVI | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about BioVie Inc.